2B70.DE vs. XDWH.DE
2B70.DE (iShares Nasdaq US Biotechnology UCITS ETF) and XDWH.DE (Xtrackers MSCI World Health Care UCITS ETF 1C) are both Health & Biotech Equities funds - 2B70.DE tracks the Nasdaq Biotechnology while XDWH.DE tracks the MSCI World/Health Care NR USD. Both are passively managed. Over the past 5 years, 2B70.DE returned 5.68%/yr vs 5.50%/yr for XDWH.DE. A 0.72 correlation means they provide meaningful diversification when combined. 2B70.DE charges 0.35%/yr vs 0.25%/yr for XDWH.DE.
Performance
2B70.DE vs. XDWH.DE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, 2B70.DE achieves a 4.53% return, which is significantly higher than XDWH.DE's -1.98% return.
2B70.DE
- 1D
- 3.29%
- 1M
- 1.98%
- YTD
- 4.53%
- 6M
- 3.42%
- 1Y
- 39.14%
- 3Y*
- 10.00%
- 5Y*
- 5.68%
- 10Y*
- —
XDWH.DE
- 1D
- 2.85%
- 1M
- 3.94%
- YTD
- -1.98%
- 6M
- -1.54%
- 1Y
- 9.60%
- 3Y*
- 2.67%
- 5Y*
- 5.50%
- 10Y*
- 7.61%
2B70.DE vs. XDWH.DE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
2B70.DE iShares Nasdaq US Biotechnology UCITS ETF | 4.53% | 18.62% | 4.60% | 2.56% | -6.29% | 7.59% | 14.52% | 30.18% | -7.35% | 2.65% |
XDWH.DE Xtrackers MSCI World Health Care UCITS ETF 1C | -1.98% | 2.21% | 7.44% | 0.04% | -0.07% | 30.55% | 2.69% | 27.24% | 5.96% | 0.92% |
Correlation
The correlation between 2B70.DE and XDWH.DE is 0.70, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.70 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.64 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.67 |
Correlation (All Time) Calculated using the full available price history since Nov 24, 2017 | 0.72 |
The correlation between 2B70.DE and XDWH.DE has been stable across timeframes, ranging from 0.64 to 0.72 - a consistent structural relationship.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
2B70.DE vs. XDWH.DE — Risk / Return Rank
2B70.DE
XDWH.DE
2B70.DE vs. XDWH.DE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for iShares Nasdaq US Biotechnology UCITS ETF (2B70.DE) and Xtrackers MSCI World Health Care UCITS ETF 1C (XDWH.DE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| 2B70.DE | XDWH.DE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.34 | ||
| Sortino ratioReturn per unit of downside risk | +1.75 | ||
| Omega ratioGain probability vs. loss probability | 1.34 | 1.13 | +0.21 |
| Calmar ratioReturn relative to maximum drawdown | 6.15 | 0.93 | +5.23 |
| Martin ratioReturn relative to average drawdown | 17.06 | 2.28 | +14.77 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| 2B70.DE | XDWH.DE | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 2.04 | 0.70 | +1.34 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.28 | 0.41 | -0.13 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.51 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.36 | 0.55 | -0.19 |
Drawdowns
2B70.DE vs. XDWH.DE - Drawdown Comparison
The maximum 2B70.DE drawdown since its inception was -30.87%, which is greater than XDWH.DE's maximum drawdown of -26.08%. Use the drawdown chart below to compare losses from any high point for 2B70.DE and XDWH.DE.
Loading charts...
Drawdown Indicators
| 2B70.DE | XDWH.DE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -30.87% | -26.08% | -4.79% |
Max Drawdown (1Y)Largest decline over 1 year | -6.33% | -10.32% | +3.99% |
Max Drawdown (3Y)Largest decline over 3 years | -29.34% | -21.12% | -8.22% |
Max Drawdown (5Y)Largest decline over 5 years | -30.87% | -21.12% | -9.75% |
Max Drawdown (10Y)Largest decline over 10 years | — | -26.08% | — |
Current DrawdownCurrent decline from peak | -1.26% | -8.51% | +7.25% |
Average DrawdownAverage peak-to-trough decline | -10.01% | -4.82% | -5.19% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 2.29% | 4.20% | -1.91% |
Volatility
2B70.DE vs. XDWH.DE - Volatility Comparison
iShares Nasdaq US Biotechnology UCITS ETF (2B70.DE) has a higher volatility of 6.65% compared to Xtrackers MSCI World Health Care UCITS ETF 1C (XDWH.DE) at 4.81%. This indicates that 2B70.DE's price experiences larger fluctuations and is considered to be riskier than XDWH.DE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| 2B70.DE | XDWH.DE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.65% | 4.81% | +1.84% |
Volatility (6M)Calculated over the trailing 6-month period | 14.26% | 9.51% | +4.75% |
Volatility (1Y)Calculated over the trailing 1-year period | 19.09% | 13.69% | +5.40% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 20.34% | 13.43% | +6.91% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 21.76% | 14.69% | +7.07% |
2B70.DE vs. XDWH.DE - Expense Ratio Comparison
2B70.DE has a 0.35% expense ratio, which is higher than XDWH.DE's 0.25% expense ratio.
Dividends
2B70.DE vs. XDWH.DE - Dividend Comparison
Neither 2B70.DE nor XDWH.DE has paid dividends to shareholders.
Frequently Asked Questions
2B70.DE and XDWH.DE have a correlation of 0.70, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, XDWH.DE is cheaper at 0.25% per year. The better choice depends on whether you care most about return, fees, risk, or income.
XDWH.DE is cheaper with a 0.25% expense ratio, compared with 0.35% for 2B70.DE.
2B70.DE tracks Nasdaq Biotechnology, while XDWH.DE tracks MSCI World/Health Care NR USD. They also come from different issuers: iShares and Xtrackers. Their fees differ too: 0.35% for 2B70.DE and 0.25% for XDWH.DE.
Find the right allocation for 2B70.DE and XDWH.DE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer